Bantam Group — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Cytotronicscytotronics.cominMar 2024
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that enables real-time monitoring of multiple cellular properties for drug discovery and cell biology research.
Deep TechMedical DevicesBoston, US
Jeffrey Abbott(Executive Officer, Director)Wenxuan Wu(Executive Officer, Director)
BoardSameer Rohatgi(Director)Jenna Abelli(Director)Douglas Kahn(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.